首页 > 最新文献

Ginekologia polska最新文献

英文 中文
Comparison of the efficacy of oral contraceptives and levonorgestrel intrauterine system in intermenstrual bleeding caused by uterine niche. 比较口服避孕药和左炔诺孕酮宫内避孕系统对子宫龛引起的月经间期出血的疗效。
IF 1.2 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-01-01 Epub Date: 2023-07-07 DOI: 10.5603/GP.a2023.0067
Fengque Zheng, Saiqiong Chen, Weiwei Yang, Jingjing Li, Qinxi Huang, Huayi Qin, Jiahan Wei, Jiajing Lin

Objectives: This study aimed to compare the effectiveness of oral contraceptives and a levonorgestrel intrauterine system in treating intermenstrual bleeding due to uterine niche.

Material and methods: We retrospectively analyzed 72 patients with intermenstrual bleeding due to uterine niche from January 2017 to December 2021, of whom 41 were treated with oral contraceptives and 31 with a levonorgestrel intrauterine system. Post-treatment follow-ups at 1, 3, and 6 months were conducted to compare the efficiency and adverse effects between the two groups.

Results: In the oral contraceptive group, the effectiveness rate was higher than 80% at 1- and 3-months post-treatment and higher than 90% at 6 months. In the levonorgestrel intrauterine system group, the effectiveness rates were 58.06%, 54.84%, and 61.29% at 1, 3, and 6 months of treatment, respectively.

Conclusions: Oral contraceptives were more effective than the levonorgestrel intrauterine system in treating intermenstrual bleeding caused by uterine niche.

研究目的本研究旨在比较口服避孕药和左炔诺孕酮宫内避孕系统治疗子宫龛引起的月经间期出血的效果:我们回顾性分析了2017年1月至2021年12月期间72例子宫龛引起的月经间期出血患者,其中41例采用口服避孕药治疗,31例采用左炔诺孕酮宫内避孕系统治疗。治疗后进行了1、3和6个月的随访,以比较两组的有效率和不良反应:结果:口服避孕药组在治疗后 1 个月和 3 个月的有效率高于 80%,6 个月的有效率高于 90%。左炔诺孕酮宫内避孕系统组在治疗后 1 个月、3 个月和 6 个月的有效率分别为 58.06%、54.84% 和 61.29%:结论:口服避孕药比左炔诺孕酮宫内避孕系统更能有效治疗子宫龛引起的月经间期出血。
{"title":"Comparison of the efficacy of oral contraceptives and levonorgestrel intrauterine system in intermenstrual bleeding caused by uterine niche.","authors":"Fengque Zheng, Saiqiong Chen, Weiwei Yang, Jingjing Li, Qinxi Huang, Huayi Qin, Jiahan Wei, Jiajing Lin","doi":"10.5603/GP.a2023.0067","DOIUrl":"10.5603/GP.a2023.0067","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to compare the effectiveness of oral contraceptives and a levonorgestrel intrauterine system in treating intermenstrual bleeding due to uterine niche.</p><p><strong>Material and methods: </strong>We retrospectively analyzed 72 patients with intermenstrual bleeding due to uterine niche from January 2017 to December 2021, of whom 41 were treated with oral contraceptives and 31 with a levonorgestrel intrauterine system. Post-treatment follow-ups at 1, 3, and 6 months were conducted to compare the efficiency and adverse effects between the two groups.</p><p><strong>Results: </strong>In the oral contraceptive group, the effectiveness rate was higher than 80% at 1- and 3-months post-treatment and higher than 90% at 6 months. In the levonorgestrel intrauterine system group, the effectiveness rates were 58.06%, 54.84%, and 61.29% at 1, 3, and 6 months of treatment, respectively.</p><p><strong>Conclusions: </strong>Oral contraceptives were more effective than the levonorgestrel intrauterine system in treating intermenstrual bleeding caused by uterine niche.</p>","PeriodicalId":12727,"journal":{"name":"Ginekologia polska","volume":" ","pages":"621-626"},"PeriodicalIF":1.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9755825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of tumor type on response to adjuvant platinum-based chemotherapy and prognosis in patients with stage II-IV epithelial ovarian carcinoma. 肿瘤类型对 II-IV 期上皮性卵巢癌患者辅助铂类化疗反应和预后的影响。
IF 1.2 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-01-01 Epub Date: 2023-09-05 DOI: 10.5603/gpl.94024
Gizem Aktemur, Cigdem Kilic, Fatih Kilic, Mehmet Ünsal, Gunsu Kimyon Comert, Taner Turan

Objectives: To evaluate the effect of histological subtype on oncological outcome and adjuvant platinum-based chemotherapy response in patients with epithelial ovarian cancer (EOC).

Material and methods: The study group was created with stage II-IV EOC patients. Progression-free survival (PFS) and disease-specific survival (DSS) estimates were determined by using the Kaplan-Meier method. The log-rank test and cox proportional hazards model were performed.

Results: A total 396 patients were included the study. Tumor type was serous in 332 (83.8%). Two hundred and thirty-one patients (58.3%) had maximal cytoreduction. Three hundred and twenty-seven (82.6%) patients received complete clinical response. Refractory disease was present in 69 (17.4%) patients. In patients with complete clinical response, 183 (56%) patients recurred. Five-year PFS was 32% in serous group and 31% in non-serous group (p = 0.755). Five-year DSS was 78% in serous group and 87% in non-serous group (p = 0.084). On multivariate analysis, recurrence rates 1.959 times (95% CI: 1.224-3.085; p = 0.004), death rates 2.624 times (95% CI: 1.328-5.185; p = 0.005) higher in patients with optimal cytoreduction than patients with maximal cytoreduction, respectively.

Conclusions: Although the rate of maximal cytoreduction was higher in patients with non-serous tumor type, the rate of refractory disease was higher after adjuvant chemotherapy. However, the recurrence rate was higher in serous tumor type. Survival rates were similar in serous and non-serous tumor types. Maximal cytoreduction was an independent predictor factor for survival. Maximal cytoreduction should be the main target in EOC.

研究目的评估组织学亚型对上皮性卵巢癌(EOC)患者的肿瘤预后和铂类辅助化疗反应的影响:研究对象为II-IV期EOC患者。采用 Kaplan-Meier 法确定无进展生存期(PFS)和疾病特异性生存期(DSS)的估计值。采用对数秩检验(log-rank test)和柯克斯比例危险模型(cox proportional hazards model):共有 396 例患者纳入研究。332例(83.8%)患者的肿瘤类型为浆液性。231名患者(58.3%)进行了最大程度的细胞减灭术。327名患者(82.6%)获得了完全临床反应。69名患者(17.4%)出现了难治性疾病。在完全临床应答的患者中,有183人(56%)复发。浆液性组五年生存率为 32%,非浆液性组为 31%(P = 0.755)。浆液性组五年 DSS 为 78%,非浆液性组为 87%(P = 0.084)。多变量分析显示,最佳细胞减灭术患者的复发率是最大细胞减灭术患者的1.959倍(95% CI:1.224-3.085;p = 0.004),死亡率是最大细胞减灭术患者的2.624倍(95% CI:1.328-5.185;p = 0.005):尽管非肉质肿瘤类型患者的最大囊肿剥除率更高,但辅助化疗后的难治性疾病率更高。然而,浆液性肿瘤的复发率更高。浆液性肿瘤和非浆液性肿瘤的生存率相似。最大程度的细胞减灭术是生存率的独立预测因素。最大程度的细胞减灭术应成为EOC的主要治疗目标。
{"title":"Effect of tumor type on response to adjuvant platinum-based chemotherapy and prognosis in patients with stage II-IV epithelial ovarian carcinoma.","authors":"Gizem Aktemur, Cigdem Kilic, Fatih Kilic, Mehmet Ünsal, Gunsu Kimyon Comert, Taner Turan","doi":"10.5603/gpl.94024","DOIUrl":"10.5603/gpl.94024","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the effect of histological subtype on oncological outcome and adjuvant platinum-based chemotherapy response in patients with epithelial ovarian cancer (EOC).</p><p><strong>Material and methods: </strong>The study group was created with stage II-IV EOC patients. Progression-free survival (PFS) and disease-specific survival (DSS) estimates were determined by using the Kaplan-Meier method. The log-rank test and cox proportional hazards model were performed.</p><p><strong>Results: </strong>A total 396 patients were included the study. Tumor type was serous in 332 (83.8%). Two hundred and thirty-one patients (58.3%) had maximal cytoreduction. Three hundred and twenty-seven (82.6%) patients received complete clinical response. Refractory disease was present in 69 (17.4%) patients. In patients with complete clinical response, 183 (56%) patients recurred. Five-year PFS was 32% in serous group and 31% in non-serous group (p = 0.755). Five-year DSS was 78% in serous group and 87% in non-serous group (p = 0.084). On multivariate analysis, recurrence rates 1.959 times (95% CI: 1.224-3.085; p = 0.004), death rates 2.624 times (95% CI: 1.328-5.185; p = 0.005) higher in patients with optimal cytoreduction than patients with maximal cytoreduction, respectively.</p><p><strong>Conclusions: </strong>Although the rate of maximal cytoreduction was higher in patients with non-serous tumor type, the rate of refractory disease was higher after adjuvant chemotherapy. However, the recurrence rate was higher in serous tumor type. Survival rates were similar in serous and non-serous tumor types. Maximal cytoreduction was an independent predictor factor for survival. Maximal cytoreduction should be the main target in EOC.</p>","PeriodicalId":12727,"journal":{"name":"Ginekologia polska","volume":" ","pages":"99-107"},"PeriodicalIF":1.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10527249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors for postpartum hemorrhage after elective cesarean deliveries for twin pregnancies. 双胎妊娠选择剖宫产术后产后出血的风险因素。
IF 1.2 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-01-01 Epub Date: 2023-08-07 DOI: 10.5603/GP.a2023.0071
Xiaojie Wan, Wei Zhao, Li Zhao, Nan Li, Hong Wen

Objectives: To identify the high-risk factors associated with postpartum hemorrhage (PPH) after an elective cesarean delivery of twins.

Material and methods: This retrospective cohort study included all women with twin gestations who chose to have an elective cesarean delivery after 28 weeks of gestation at at the Women's Hospital, School of Medicine, Zhejiang University between September 2014 and April 2019. Women with an intrauterine fetal demise of one or both twins were excluded. PPH was defined as an estimated blood loss of ≥ 1,000 mL within 24 h of birth. A total of 532 women were analyzed and classified into the PPH group (n = 70) and the no-PPH group (n = 462). Univariate and multivariate logistic regression analyses were performed to assess the independent risk factors.

Results: Among the 532 women pregnant with twins, PPH occurred in 13.2% women (n = 70). There were statistically significant differences in preeclampsia (p = 0.005), premature rupture of membrane (PROM, p < 0.001), placenta previa (p < 0.001), anemia [hemoglobin (Hb) < 100 g/L; p = 0.003], and antenatal magnesium sulfate (MgSO₄) use (p < 0.001) between the two groups. However, the following were the independent risk factors for PPH after an elective cesarean delivery for a twin pregnancy: preeclampsia [odds ratio (OR): 2.91; 95% confidence interval (CI): 1.33-6.36], PROM (OR: 8.57; 95% CI: 2.54-28.89), placenta previa (OR: 9.46; 95% CI: 3.59-24.89), antenatal MgSO₄ use (OR: 7.64; 95% CI; 3.18-18.41), and anemia (Hb < 100 g/L; OR: 2.68; 95% CI: 1.42-5.06).

Conclusions: Preeclampsia, PROM, placenta previa,and antenatal MgSO₄ use were the risk factors for PPH after an elective cesarean delivery for twin pregnancies. Risk factor identification and prevention should be a priority.

摘要材料与方法:这项回顾性队列研究纳入了2014年9月至2019年4月期间在浙江大学医学院附属妇产科医院妊娠28周后选择择期剖宫产的所有双胎产妇。排除了一胎或双胎胎死宫内的产妇。PPH定义为出生后24小时内估计失血量≥1,000毫升。共对 532 名产妇进行了分析,并将其分为 PPH 组(n = 70)和无 PPH 组(n = 462)。对独立风险因素进行了单变量和多变量逻辑回归分析:在 532 名怀有双胞胎的妇女中,13.2% 的妇女(n = 70)发生了 PPH。两组孕妇在先兆子痫(p = 0.005)、胎膜早破(PROM,p < 0.001)、前置胎盘(p < 0.001)、贫血[血红蛋白(Hb)< 100 g/L; p = 0.003]和产前硫酸镁(MgSO₄)使用量(p < 0.001)方面存在统计学差异。然而,以下因素是双胎妊娠选择剖宫产后发生 PPH 的独立危险因素:子痫前期[几率比(OR):2.91;95% 置信区间(CI):1.33-6.36]、PROM(OR:1.33-6.36)、PPH(OR:1.33-6.36)、PPH(OR:1.33-6.36)、PPH(OR:1.33-6.36)。36]、PROM(OR:8.57;95% CI:2.54-28.89)、前置胎盘(OR:9.46;95% CI:3.59-24.89)、产前使用 MgSO₄(OR:7.64;95% CI;3.18-18.41)和贫血(Hb < 100 g/L;OR:2.68;95% CI:1.42-5.06):结论:子痫前期、PROM、前置胎盘和产前服用硫酸镁₄是双胎妊娠择期剖宫产后发生 PPH 的危险因素。风险因素的识别和预防应放在首位。
{"title":"Risk factors for postpartum hemorrhage after elective cesarean deliveries for twin pregnancies.","authors":"Xiaojie Wan, Wei Zhao, Li Zhao, Nan Li, Hong Wen","doi":"10.5603/GP.a2023.0071","DOIUrl":"10.5603/GP.a2023.0071","url":null,"abstract":"<p><strong>Objectives: </strong>To identify the high-risk factors associated with postpartum hemorrhage (PPH) after an elective cesarean delivery of twins.</p><p><strong>Material and methods: </strong>This retrospective cohort study included all women with twin gestations who chose to have an elective cesarean delivery after 28 weeks of gestation at at the Women's Hospital, School of Medicine, Zhejiang University between September 2014 and April 2019. Women with an intrauterine fetal demise of one or both twins were excluded. PPH was defined as an estimated blood loss of ≥ 1,000 mL within 24 h of birth. A total of 532 women were analyzed and classified into the PPH group (n = 70) and the no-PPH group (n = 462). Univariate and multivariate logistic regression analyses were performed to assess the independent risk factors.</p><p><strong>Results: </strong>Among the 532 women pregnant with twins, PPH occurred in 13.2% women (n = 70). There were statistically significant differences in preeclampsia (p = 0.005), premature rupture of membrane (PROM, p < 0.001), placenta previa (p < 0.001), anemia [hemoglobin (Hb) < 100 g/L; p = 0.003], and antenatal magnesium sulfate (MgSO₄) use (p < 0.001) between the two groups. However, the following were the independent risk factors for PPH after an elective cesarean delivery for a twin pregnancy: preeclampsia [odds ratio (OR): 2.91; 95% confidence interval (CI): 1.33-6.36], PROM (OR: 8.57; 95% CI: 2.54-28.89), placenta previa (OR: 9.46; 95% CI: 3.59-24.89), antenatal MgSO₄ use (OR: 7.64; 95% CI; 3.18-18.41), and anemia (Hb < 100 g/L; OR: 2.68; 95% CI: 1.42-5.06).</p><p><strong>Conclusions: </strong>Preeclampsia, PROM, placenta previa,and antenatal MgSO₄ use were the risk factors for PPH after an elective cesarean delivery for twin pregnancies. Risk factor identification and prevention should be a priority.</p>","PeriodicalId":12727,"journal":{"name":"Ginekologia polska","volume":" ","pages":"531-535"},"PeriodicalIF":1.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10303557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adverse pregnancy outcomes for women with endometriosis: a systematic review and meta-analysis. 子宫内膜异位症妇女的不良妊娠结局:系统回顾和荟萃分析。
IF 1.2 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-01-01 Epub Date: 2021-09-20 DOI: 10.5603/GP.a2021.0081
Jian-Qing Wang, Jia-Miao Zhang, Bin Qian

Objectives: This study aimed at assessing the adverse outcomes of pregnancy in women with endometriosis.

Material and methods: The Cochrane, Embase and PubMed databases were searched for identifying the required studies published before June 2019. Meta-analyses of relative risk (RR) were performed under the random-effects model to estimate the risk of selected adverse outcomes of pregnancy in females with endometriosis.

Results: Twenty-eight studies (53,141 women with and 2,355,923 women without endometriosis data) were selected for meta-analysis. Endometriosis bearing females had a significantly higher risk placenta previa (RR 3.92 [95% CI 2.48-6.20]), miscarriage (RR 1.31 [95% CI 1.06-1.61), gestational hypertension (RR 1.30 [95% CI 1.02-1.65]), cesarean section (RR 1.48 [95% CI 1.33-1.65]) and preeclampsia (RR 1.18 [95% CI 1.09-1.28]). The incidence of placental abruption was not statistically significant between the groups (RR 3.62 [95% CI [0.99-13.28]).

Conclusions: Women suffering from endometriosis are at higher risks of miscarriage, preterm birth, gestational hypertension, placenta previa, cesarean section, and preeclampsia.

研究目的本研究旨在评估子宫内膜异位症女性的不良妊娠结局:对Cochrane、Embase和PubMed数据库进行检索,以确定2019年6月之前发表的所需研究。在随机效应模型下进行相对风险(RR)元分析,以估计子宫内膜异位症女性妊娠不良结局的风险:荟萃分析选取了 28 项研究(53 141 名患有子宫内膜异位症的女性和 2 355 923 名未患有子宫内膜异位症的女性)。患有子宫内膜异位症的女性发生前置胎盘(RR 3.92 [95% CI 2.48-6.20])、流产(RR 1.31 [95% CI 1.06-1.61])、妊娠高血压(RR 1.30 [95% CI 1.02-1.65])、剖宫产(RR 1.48 [95% CI 1.33-1.65])和子痫前期(RR 1.18 [95% CI 1.09-1.28])的风险明显更高。胎盘早剥的发生率在各组之间没有统计学意义(RR 3.62 [95% CI [0.99-13.28]):结论:患有子宫内膜异位症的妇女流产、早产、妊娠高血压、前置胎盘、剖宫产和子痫前期的风险较高。
{"title":"Adverse pregnancy outcomes for women with endometriosis: a systematic review and meta-analysis.","authors":"Jian-Qing Wang, Jia-Miao Zhang, Bin Qian","doi":"10.5603/GP.a2021.0081","DOIUrl":"10.5603/GP.a2021.0081","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed at assessing the adverse outcomes of pregnancy in women with endometriosis.</p><p><strong>Material and methods: </strong>The Cochrane, Embase and PubMed databases were searched for identifying the required studies published before June 2019. Meta-analyses of relative risk (RR) were performed under the random-effects model to estimate the risk of selected adverse outcomes of pregnancy in females with endometriosis.</p><p><strong>Results: </strong>Twenty-eight studies (53,141 women with and 2,355,923 women without endometriosis data) were selected for meta-analysis. Endometriosis bearing females had a significantly higher risk placenta previa (RR 3.92 [95% CI 2.48-6.20]), miscarriage (RR 1.31 [95% CI 1.06-1.61), gestational hypertension (RR 1.30 [95% CI 1.02-1.65]), cesarean section (RR 1.48 [95% CI 1.33-1.65]) and preeclampsia (RR 1.18 [95% CI 1.09-1.28]). The incidence of placental abruption was not statistically significant between the groups (RR 3.62 [95% CI [0.99-13.28]).</p><p><strong>Conclusions: </strong>Women suffering from endometriosis are at higher risks of miscarriage, preterm birth, gestational hypertension, placenta previa, cesarean section, and preeclampsia.</p>","PeriodicalId":12727,"journal":{"name":"Ginekologia polska","volume":" ","pages":"668-676"},"PeriodicalIF":1.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39431891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoglin promotes cell migration and invasion in endometriosis by regulating EMT. Endoglin 通过调节 EMT 促进子宫内膜异位症的细胞迁移和侵袭。
IF 1.2 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-01-01 Epub Date: 2021-09-20 DOI: 10.5603/GP.a2021.0130
Xiutang Chen, Junjian Wang, Feixia Tu, Qing Yang, Dan Wang, Qin Zhu

Objectives: This study aims to investigate the expression and role of Endoglin (ENG) in endometriosis (EM).

Material and methods: In this study, quantitative real-time polymerase chain reaction, western blot and immunohistochemistry were used to examine the expression of ENG in tissues. Cellular experiments were performed to evaluate the effect of ENG on cellular biological function. Western blot was used to examine the expression of epithelial to mesenchymal transition-related proteins.

Results: The expression of ENG was significantly higher in the ectopic endometriotic tissues than that in eutopic endometriotic tissues. Knockdown of ENG inhibited cell viability, migration and invasion, and induced cell apoptosis in hEM15A cells. Additionally, silenced ENG caused increased levels of E-cadherin and decreased levels of N-cadherin, vimentin, MMP-2 and MMP-9.

Conclusions: These results confirmed that ENG may be involved in the development of endometriosis by promoting EMT process, revealing a new insight into the pathogenesis of endometriosis and contributing to the exploration of molecular therapeutic strategies against endometriosis.

研究目的本研究旨在探讨子宫内膜异位症(EM)中Endoglin(ENG)的表达和作用:本研究采用实时定量聚合酶链反应、Western 印迹和免疫组织化学方法检测ENG在组织中的表达。细胞实验用于评估ENG对细胞生物功能的影响。Western 印迹用于检测上皮细胞向间充质转化相关蛋白的表达:结果:异位子宫内膜异位组织中ENG的表达明显高于异位子宫内膜异位组织。在 hEM15A 细胞中,敲除 ENG 可抑制细胞活力、迁移和侵袭,并诱导细胞凋亡。此外,沉默的ENG导致E-cadherin水平升高,N-cadherin、波形蛋白、MMP-2和MMP-9水平降低:这些结果证实了ENG可能通过促进EMT过程参与了子宫内膜异位症的发展,揭示了子宫内膜异位症发病机制的新见解,有助于探索子宫内膜异位症的分子治疗策略。
{"title":"Endoglin promotes cell migration and invasion in endometriosis by regulating EMT.","authors":"Xiutang Chen, Junjian Wang, Feixia Tu, Qing Yang, Dan Wang, Qin Zhu","doi":"10.5603/GP.a2021.0130","DOIUrl":"10.5603/GP.a2021.0130","url":null,"abstract":"<p><strong>Objectives: </strong>This study aims to investigate the expression and role of Endoglin (ENG) in endometriosis (EM).</p><p><strong>Material and methods: </strong>In this study, quantitative real-time polymerase chain reaction, western blot and immunohistochemistry were used to examine the expression of ENG in tissues. Cellular experiments were performed to evaluate the effect of ENG on cellular biological function. Western blot was used to examine the expression of epithelial to mesenchymal transition-related proteins.</p><p><strong>Results: </strong>The expression of ENG was significantly higher in the ectopic endometriotic tissues than that in eutopic endometriotic tissues. Knockdown of ENG inhibited cell viability, migration and invasion, and induced cell apoptosis in hEM15A cells. Additionally, silenced ENG caused increased levels of E-cadherin and decreased levels of N-cadherin, vimentin, MMP-2 and MMP-9.</p><p><strong>Conclusions: </strong>These results confirmed that ENG may be involved in the development of endometriosis by promoting EMT process, revealing a new insight into the pathogenesis of endometriosis and contributing to the exploration of molecular therapeutic strategies against endometriosis.</p>","PeriodicalId":12727,"journal":{"name":"Ginekologia polska","volume":" ","pages":"661-667"},"PeriodicalIF":1.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39431986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Using progesterone to follicular index ratio is better correlated with intracytoplasmic sperm injection outcome than using serum progesterone level alone. 与单纯使用血清孕酮水平相比,使用孕酮与卵泡指数比值与卵胞浆内单精子注射结果的相关性更好。
IF 1.2 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-01-01 Epub Date: 2023-05-30 DOI: 10.5603/GP.a2023.0031
Athba Abid Kadhim, Thuraya Hussamuldeen Abdulla, Ula Mohammad Alkawaz

Objectives: to investigate the possibility of using the ratio of serum progesterone level to the number of follicles, according to ovarian response in the day of human chorionic gonadotrophin trigger, as a predictor of cycle outcome.

Material and methods: A prospective intervensional study was conducted at Kamal Al-Samarai Hospital for Infertility Treatment and IVF during the period from December 2020 to September 2021. Ninety infertile women underwent intracytoplasmic sperm injection (ICSI) cycles using antagonist protocol. Moreover, once the patient reached triggering criteria, meticulous recording of follicular index together with serum estrogen level and serum progesterone level are measured. Fresh embryo transfer of cleavage stage embryo is done once serum progesterone level was less than 1.5 ng/mL. A follow-up to confirm pregnancy rate and cycle outcome was done.

Results: The study showed a positive pregnancy rate of 28.9%. The relationship between progesterone follicular index (Prog/FI) ratio and (ICSI) outcome was highly significant with a p value of 0.001. Additionally, an inverse relationship, as the ratio was lower the pregnancy rate was improved, was documented. The receiver operating characteristic (ROC) curve for progesterone follicular index ratio was 0.711 with a cut off value of 0.0354 ng/mL in addition to a sensitivity of 65.6 and a specificity of 65.4.

Conclusions: The serum progesterone level is an independent factor for the prediction of intracytoplasmic sperm injection (ICSI) outcome, whereas the progesterone follicular index ratio can be used as a potential marker for predicting ICSI outcome in fresh embryo transfer.

目的:根据人绒毛膜促性腺激素触发日的卵巢反应,研究使用血清孕酮水平与卵泡数量之比作为周期结果预测指标的可能性:2020 年 12 月至 2021 年 9 月期间,卡迈勒萨马拉伊不孕不育治疗和试管婴儿医院开展了一项前瞻性干预研究。90名不孕妇女接受了使用拮抗剂方案的卵胞浆内单精子显微注射(ICSI)周期。此外,一旦患者达到触发标准,就会对卵泡指数、血清雌激素水平和血清孕酮水平进行详细记录。一旦血清孕酮水平低于 1.5 纳克/毫升,就会进行卵裂期胚胎的新胚胎移植。随访确认妊娠率和周期结果:研究显示,阳性妊娠率为 28.9%。孕酮卵泡指数(Prog/FI)比值与(ICSI)结果之间的关系非常显著,P值为0.001。此外,两者之间还存在反比关系,即比率越低,妊娠率越高。孕酮卵泡指数比值的接收者操作特征曲线(ROC)为 0.711,临界值为 0.0354 ng/mL,敏感性为 65.6,特异性为 65.4:血清孕酮水平是预测卵胞浆内单精子显微注射(ICSI)结果的一个独立因素,而孕酮卵泡指数比值可作为预测新鲜胚胎移植中ICSI结果的潜在标志物。
{"title":"Using progesterone to follicular index ratio is better correlated with intracytoplasmic sperm injection outcome than using serum progesterone level alone.","authors":"Athba Abid Kadhim, Thuraya Hussamuldeen Abdulla, Ula Mohammad Alkawaz","doi":"10.5603/GP.a2023.0031","DOIUrl":"10.5603/GP.a2023.0031","url":null,"abstract":"<p><strong>Objectives: </strong>to investigate the possibility of using the ratio of serum progesterone level to the number of follicles, according to ovarian response in the day of human chorionic gonadotrophin trigger, as a predictor of cycle outcome.</p><p><strong>Material and methods: </strong>A prospective intervensional study was conducted at Kamal Al-Samarai Hospital for Infertility Treatment and IVF during the period from December 2020 to September 2021. Ninety infertile women underwent intracytoplasmic sperm injection (ICSI) cycles using antagonist protocol. Moreover, once the patient reached triggering criteria, meticulous recording of follicular index together with serum estrogen level and serum progesterone level are measured. Fresh embryo transfer of cleavage stage embryo is done once serum progesterone level was less than 1.5 ng/mL. A follow-up to confirm pregnancy rate and cycle outcome was done.</p><p><strong>Results: </strong>The study showed a positive pregnancy rate of 28.9%. The relationship between progesterone follicular index (Prog/FI) ratio and (ICSI) outcome was highly significant with a p value of 0.001. Additionally, an inverse relationship, as the ratio was lower the pregnancy rate was improved, was documented. The receiver operating characteristic (ROC) curve for progesterone follicular index ratio was 0.711 with a cut off value of 0.0354 ng/mL in addition to a sensitivity of 65.6 and a specificity of 65.4.</p><p><strong>Conclusions: </strong>The serum progesterone level is an independent factor for the prediction of intracytoplasmic sperm injection (ICSI) outcome, whereas the progesterone follicular index ratio can be used as a potential marker for predicting ICSI outcome in fresh embryo transfer.</p>","PeriodicalId":12727,"journal":{"name":"Ginekologia polska","volume":" ","pages":"525-530"},"PeriodicalIF":1.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9542220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic potential of microRNAs Mi 517 and Mi 526 as biomarkers in the detection of hypertension and preeclampsia in the first trimester. microrna Mi 517和Mi 526作为早期妊娠高血压和子痫前期生物标志物的诊断潜力
IF 1.2 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-01-01 Epub Date: 2023-04-12 DOI: 10.5603/GP.a2023.0036
Adrianna Kondracka, Bartosz Kondracki, Ilona Jaszczuk, Jakub Staniczek, Wojciech Kwasniewski, Agata Filip, Anna Kwasniewska

Objectives: MicroRNAs have been observed to play a major role in various physiological processes, for instance, programmed cell death, cell division, pregnancy development, and proliferation. With the help of profiling of microRNAs in the serum of pregnant women, it is possible to link alterations in their concentration to the emergence of gestational problems. The aim of the study was to evaluate the diagnostic potential of MicroRNAs Mi 517 and Mi 526 as biomarkers in the detection of hypertension and preeclampsia.

Material and methods: The study considered 53 patients who are in their first trimester of a singleton pregnancy. Participants have been divided into two study groups, one group with normal pregnancy and another group having the risk of developing preeclampsia or who developed hypertension or preeclampsia during follow-up constitute the study group. In order to collect data associated with circulating miRNAs in serum, blood samples have been collected from the participants of the study.

Results: Based on the univariate regression model, increased expression of Mi 517 and 526 and parity status (primapara/multipara) has been obtained. The multivariate logistic analysis shows that independent risk factors for hypertension or preeclampsia are the presence of an R527 and being a primipara.

Conclusions: The study's findings have revealed that R517s and R526s act as major indicative biomarkers in the first trimester for the detection of hypertension and preeclampsia. The circulating C19MC MicroRNA was examined as a potential early indicator of preeclampsia and hypertension in pregnant individuals.

目的:已经观察到microrna在各种生理过程中发挥重要作用,例如细胞程序性死亡、细胞分裂、妊娠发育和增殖。借助对孕妇血清中microrna的分析,有可能将其浓度的变化与妊娠问题的出现联系起来。该研究的目的是评估microrna Mi 517和Mi 526作为检测高血压和子痫前期生物标志物的诊断潜力。材料和方法:该研究考虑了53例处于单胎妊娠早期的患者。参与者被分为两个研究组,一组正常妊娠,另一组有发生子痫前期的风险或在随访期间发生高血压或子痫前期的为研究组。为了收集与血清中循环mirna相关的数据,研究人员收集了研究参与者的血液样本。结果:基于单变量回归模型,获得了Mi 517和526的表达增加和奇偶状态(primapara/multipara)。多因素logistic分析显示,存在R527和初产妇是高血压或子痫前期的独立危险因素。结论:该研究结果表明,r517和r526是妊娠早期检测高血压和子痫前期的主要指示性生物标志物。循环C19MC MicroRNA被检测为孕妇子痫前期和高血压的潜在早期指标。
{"title":"Diagnostic potential of microRNAs Mi 517 and Mi 526 as biomarkers in the detection of hypertension and preeclampsia in the first trimester.","authors":"Adrianna Kondracka, Bartosz Kondracki, Ilona Jaszczuk, Jakub Staniczek, Wojciech Kwasniewski, Agata Filip, Anna Kwasniewska","doi":"10.5603/GP.a2023.0036","DOIUrl":"10.5603/GP.a2023.0036","url":null,"abstract":"<p><strong>Objectives: </strong>MicroRNAs have been observed to play a major role in various physiological processes, for instance, programmed cell death, cell division, pregnancy development, and proliferation. With the help of profiling of microRNAs in the serum of pregnant women, it is possible to link alterations in their concentration to the emergence of gestational problems. The aim of the study was to evaluate the diagnostic potential of MicroRNAs Mi 517 and Mi 526 as biomarkers in the detection of hypertension and preeclampsia.</p><p><strong>Material and methods: </strong>The study considered 53 patients who are in their first trimester of a singleton pregnancy. Participants have been divided into two study groups, one group with normal pregnancy and another group having the risk of developing preeclampsia or who developed hypertension or preeclampsia during follow-up constitute the study group. In order to collect data associated with circulating miRNAs in serum, blood samples have been collected from the participants of the study.</p><p><strong>Results: </strong>Based on the univariate regression model, increased expression of Mi 517 and 526 and parity status (primapara/multipara) has been obtained. The multivariate logistic analysis shows that independent risk factors for hypertension or preeclampsia are the presence of an R527 and being a primipara.</p><p><strong>Conclusions: </strong>The study's findings have revealed that R517s and R526s act as major indicative biomarkers in the first trimester for the detection of hypertension and preeclampsia. The circulating C19MC MicroRNA was examined as a potential early indicator of preeclampsia and hypertension in pregnant individuals.</p>","PeriodicalId":12727,"journal":{"name":"Ginekologia polska","volume":" ","pages":"952-958"},"PeriodicalIF":1.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9284556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical significance of S100B protein in pregnant woman with early- onset severe preeclampsia. 早发重度子痫前期孕妇体内 S100B 蛋白的临床意义。
IF 1.2 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-01-01 Epub Date: 2021-06-09 DOI: 10.5603/GP.a2021.0126
Jinxia Wu, Xiaoqi Sheng, Shaoming Zhou, Chaoying Fang, Yulin Song, Hua Wang, Zhengjun Jia, Xiaozhou Jia, Yiping You

Objectives: Preeclampsia is one of the most feared complications of pregnancy, which can progress rapidly to serious complications such as death of both mother and fetus. To present, the leading cause of preeclampsia is still debated. The purpose of this article was to explore the clinical significance of S100B protein, a kind of Ca2+ -sensor protein, in the early-onset severe preeclampsia.

Material and methods: Nine pregnant women with early-onset severe preeclampsia (the study group) and 13 healthy pregnant women (the control group) were included in this study. The level of S100B in the amniotic fluid, maternal blood, and umbilical cord blood were detected by enzyme-linked immunosorbent assay (ELISA) and surface plasmon resonance imaging (SPRi) methods. Diagnostic values of S100B for early-onset severe preeclampsia were assessed by Receiver Operating Characteristic (ROC) curve analysis.

Results: The levels of S100B in maternal blood and amniotic fluid in the study group were higher than those in the control group (p < 0.05). ROC curve analysis showed that S100B detected by SPRi method (SPRi-S100B) showed a cut-off level of 181 ng/mL with sensitivity of 100%, a specificity of 84.6%, and a Youden index of 0.846 in the maternal blood, which had better clinical significance and diagnostic value (at than that detected by ELISA (ELISA-S100B).

Conclusions: The levels of S100B detected by SPRi in maternal blood can indicate early-onset severe preeclampsia and perinatal brain injury.

目的:子痫前期是最可怕的妊娠并发症之一,可迅速发展为严重并发症,如母亲和胎儿死亡。目前,子痫前期的主要病因仍存在争议。本文旨在探讨S100B蛋白(一种Ca2+传感蛋白)在早发重度子痫前期中的临床意义:材料:本研究纳入了9名早发重度子痫前期孕妇(研究组)和13名健康孕妇(对照组)。采用酶联免疫吸附试验(ELISA)和表面等离子体共振成像(SPRi)方法检测羊水、母血和脐带血中的 S100B 水平。通过接收者操作特征曲线(ROC)分析评估了S100B对早发重度子痫前期的诊断价值:研究组母体血液和羊水中的 S100B 水平均高于对照组(P < 0.05)。ROC曲线分析显示,SPRi法(SPRi-S100B)检测的S100B临界值为181 ng/mL,灵敏度为100%,特异性为84.6%,Youden指数为0.846,与ELISA法(ELISA-S100B)相比具有更好的临床意义和诊断价值:结论:通过SPRi检测母体血液中的S100B水平可预示早期重度子痫前期和围产期脑损伤。
{"title":"Clinical significance of S100B protein in pregnant woman with early- onset severe preeclampsia.","authors":"Jinxia Wu, Xiaoqi Sheng, Shaoming Zhou, Chaoying Fang, Yulin Song, Hua Wang, Zhengjun Jia, Xiaozhou Jia, Yiping You","doi":"10.5603/GP.a2021.0126","DOIUrl":"10.5603/GP.a2021.0126","url":null,"abstract":"<p><strong>Objectives: </strong>Preeclampsia is one of the most feared complications of pregnancy, which can progress rapidly to serious complications such as death of both mother and fetus. To present, the leading cause of preeclampsia is still debated. The purpose of this article was to explore the clinical significance of S100B protein, a kind of Ca2+ -sensor protein, in the early-onset severe preeclampsia.</p><p><strong>Material and methods: </strong>Nine pregnant women with early-onset severe preeclampsia (the study group) and 13 healthy pregnant women (the control group) were included in this study. The level of S100B in the amniotic fluid, maternal blood, and umbilical cord blood were detected by enzyme-linked immunosorbent assay (ELISA) and surface plasmon resonance imaging (SPRi) methods. Diagnostic values of S100B for early-onset severe preeclampsia were assessed by Receiver Operating Characteristic (ROC) curve analysis.</p><p><strong>Results: </strong>The levels of S100B in maternal blood and amniotic fluid in the study group were higher than those in the control group (p < 0.05). ROC curve analysis showed that S100B detected by SPRi method (SPRi-S100B) showed a cut-off level of 181 ng/mL with sensitivity of 100%, a specificity of 84.6%, and a Youden index of 0.846 in the maternal blood, which had better clinical significance and diagnostic value (at than that detected by ELISA (ELISA-S100B).</p><p><strong>Conclusions: </strong>The levels of S100B detected by SPRi in maternal blood can indicate early-onset severe preeclampsia and perinatal brain injury.</p>","PeriodicalId":12727,"journal":{"name":"Ginekologia polska","volume":" ","pages":"711-717"},"PeriodicalIF":1.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39077413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The 18-year-old-girl with unicornuate uterus and endometriosis. 患有单角子宫和子宫内膜异位症的 18 岁女孩。
IF 1.2 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-01-01 Epub Date: 2023-04-12 DOI: 10.5603/GP.a2023.0040
Yana Osnytska, Rafal Stojko, Agnieszka Drosdzol-Cop
{"title":"The 18-year-old-girl with unicornuate uterus and endometriosis.","authors":"Yana Osnytska, Rafal Stojko, Agnieszka Drosdzol-Cop","doi":"10.5603/GP.a2023.0040","DOIUrl":"10.5603/GP.a2023.0040","url":null,"abstract":"","PeriodicalId":12727,"journal":{"name":"Ginekologia polska","volume":" ","pages":"167-168"},"PeriodicalIF":1.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9277231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Squamous cell carcinoma evolving from mature cystic teratoma of the ovary. 从卵巢成熟囊性畸胎瘤演变而来的鳞状细胞癌。
IF 1.2 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-01-01 Epub Date: 2023-09-19 DOI: 10.5603/gpl.96501
Marlena Cwynar, Karolina Kowalczyk, Grzegorz Cwynar, Piotr Ptak, Mykola Chekan
{"title":"Squamous cell carcinoma evolving from mature cystic teratoma of the ovary.","authors":"Marlena Cwynar, Karolina Kowalczyk, Grzegorz Cwynar, Piotr Ptak, Mykola Chekan","doi":"10.5603/gpl.96501","DOIUrl":"10.5603/gpl.96501","url":null,"abstract":"","PeriodicalId":12727,"journal":{"name":"Ginekologia polska","volume":" ","pages":"414-415"},"PeriodicalIF":1.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10303017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Ginekologia polska
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1